This study identifies TP53RK as a key regulator of colorectal cancer (CRC) cell survival by stabilizing CDC7 for proper DNA replication. Its loss causes replication stress, apoptosis, and cell cycle arrest, making TP53RK a promising therapeutic target for CRC.